RNA Analysis Transcriptomics Market Growing Demand, Opportunities and Share Analysis 2022 to 2028

According to Precision Business Insights (PBI), the latest report the global RNA Analysis/ Transcriptomics Market is expected to be worth USD 8,648.3 million in 2022 and projected to grow at a 16.9% CAGR over 2022 to 2028. The surge in demand for personalised medicine, increased pharmaceutical and biotechnology R&D expenditure, government funding for omics, rise in RNA sequencing applications, and development of new transcriptomics products by a large number of key players are driving growth in the global transcriptomics market.

View the detailed report description here - https://precisionbusinessinsights.com/market-reports/rna-analysis-transcriptomics-market/

The Consumables Segment is Dominating the Global RNA Analysis/ Transcriptomics Market:
The reagents/consumables segment is expected to account for a larger revenue share and the market is expected to grow at double digit growth rate over the forecast years owing the growing need for high-quality reagents, as well as the frequent usage of medium and reagents in transcriptome investigations. Furthermore, rising R&D activities in the pharmaceutical business, rising government spending in life science research, and rising research with integrated omics studies are all adding to the market for consumables.

North America Leads Global RNA Analysis/ Transcriptomics Market:
North America is expected to hold significant market share in the Global RNA Analysis/ Transcriptomics market and is projected to grow at a prominent growth rate over the forecast years. The region's large market share can be attributed to an increase in the development of structure-based drug designs, an increase in academic and government investments in genomics and proteomics research, a surge in life science research funding, a surge in biopharmaceutical R&D expenditure, and an increase in the adoption of advanced technologies. A high number of global players' presence also contributed to North America's large market share.

Strategic New Product Launches, Mergers, Acquisitions and Agreements are the key strategies adopted by market players:
The global RNA Analysis/ Transcriptomics Market further reveals that the key players increasingly adopting strategies such as launch of newer products, product launches, and long-term alliance to improve market revenue share and gaining significant geographic presence across the region. For instance, In 2020, Agilent Technologies launched its SureSelect XT HS2 RNA Reagent Kit. In 2020, Merck KGaA invested USD 21.32 million in a new Life Science Laboratory in Switzerland.

Request sample report at https://precisionbusinessinsights.com/request-sample?product_id=60691

The global rna analysis/ transcriptomics market is segmented based on type, technology, application, and geography.
Based on the type, the market is segmented into the following:
• Consumables
• Instruments
• Software
• Services

Based on the technology, the market is segmented into the following:
• Microarrays
• q PCR
• Sequencing Technology

Based on the Application, the market is segmented into the following:
• Drug Discovery
• Diagnostics and Disease Profiling
• Others

Based on Geography, the market is segmented into the following:
• North America
• Europe
• Asia Pacific
• Latin America
• MEA

Request Methodology: https://precisionbusinessinsights.com/request-methodology?product_id=60691

Key player's profiles in the global rna analysis/ transcriptomics market report are Agilent Technologies Inc., Bio-Rad Laboratories, F-Hoffmann La-Roche, Fluidigm Corporation, General Electric Company, Illuminia Inc., Merck & Co. Inc, Promega Corporation, QiagenInc, Thermofisher Scientific.

Contact:
Mr. Satya
Precision Business InsightsTM | Toll Free: +1 866 598 1553
Email: sales@precisionbusinessinsights.com
Kemp House, 152 - 160 City Road, London EC1V 2NX
Web: https://precisionbusinessinsights.com/ | D U N S® Number: 852781747

About Precision Business Insights:
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers. Precision Business Insights offers a variety of cost-effective and customized research services to meet research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.

This release was published on openPR.